Recommendations for hepatitis B immunoglobulin and antiviral prophylaxis against hepatitis B recurrence after liver transplantation

dc.authorid0000-0002-1240-7233
dc.contributor.authorAkarsu, Mesut
dc.contributor.authorÖnem, Soner
dc.contributor.authorTuran, İlker
dc.contributor.authorAdalı, Gupse
dc.contributor.authorAkdoğan, Meral
dc.contributor.authorAkyıldız, Murat
dc.contributor.authorAladağ, Murat
dc.contributor.authorBalaban, Yasemin
dc.contributor.authorDanış, Nilay
dc.contributor.authorDayangaç, Murat
dc.contributor.authorGençdal, Genco
dc.contributor.authorGökcan, Hale
dc.contributor.authorSertesen, Elif
dc.contributor.authorGürakar, Merve
dc.contributor.authorHarputluoğlu, Murat
dc.contributor.authorKabaçam, Gökhan
dc.contributor.authorKarademir, Sedat
dc.contributor.authorKıyıcı, Murat
dc.contributor.authorİdilman, Ramazan
dc.contributor.authorKarasu, Zeki
dc.date.accessioned2021-10-21T06:48:19Z
dc.date.available2021-10-21T06:48:19Z
dc.date.issued2021
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Organ Nakli Ana Bilim Dalı
dc.description.abstractThe combination of hepatitis B immunoglobulin and potent nucleos(t)ide analogs after liver transplantation is considered as the standard of care for prophylaxis against hepatitis B virus recurrence. However, the recommended doses, route of administration, and duration of HBIG administration remain unclear. Moreover, hepatitis B immunoglobulin-free prophylaxis with potent nucleos(t)ide analogs has shown promising disease outcomes in preventing hepatitis B virus recurrence. The current recommendations, produced by the Turkish Association for the Study of the Liver, Acute Liver Failure and Liver Transplantation Special Interest Group, suggest a reduced need for hepatitis B immunoglobulin administration with effective long-term suppression of hepatitis B virus replication using potent nucleos(t)ide analogs after liver transplantation.
dc.identifier.citationAkarsu, M., Önem, S., Turan, İ., Adalı, G., Akdoğan, M., Akyıldız, M. ... Karasu, Z. (2021). Recommendations for hepatitis B immunoglobulin and antiviral prophylaxis against hepatitis B recurrence after liver transplantation. Turkish Journal of Gastroenterology, 32(9), 712-719. https://dx.doi.org/10.5152/tjg.2021.21608
dc.identifier.doi10.5152/tjg.2021.21608
dc.identifier.endpage719
dc.identifier.issn2148-5607
dc.identifier.issue9
dc.identifier.scopusqualityQ3
dc.identifier.startpage712
dc.identifier.trdizinid512595
dc.identifier.urihttps://dx.doi.org/10.5152/tjg.2021.21608
dc.identifier.urihttps://hdl.handle.net/20.500.12511/8492
dc.identifier.volume32
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakTR-Dizin
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherAVES
dc.relation.ispartofTurkish Journal of Gastroenterologyen_US
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/embargoedAccess
dc.subjectHepatitis B
dc.subjectLiver Transplantation
dc.subjectRecurrence
dc.titleRecommendations for hepatitis B immunoglobulin and antiviral prophylaxis against hepatitis B recurrence after liver transplantation
dc.typeReview Article

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
Dayangacc-Murat-2021.pdf
Boyut:
1.07 MB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: